Xtant Medical Holdings, Inc. (XTNT)
News
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Accesswire BELGRADE, MT / ACCESSWIRE / May 22, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders...\n more…
Xtant Medical Announces Launch of SimpliGraft and SimpliMax for Chronic and Acute Wounds
Globe Newswire BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal...\n more…
Xtant Medical Announces Second Quarter Revenue Growth of 32%
Globe Newswire Raises 2023 Annual Revenue Guidance to $75 Million - $77 Million BELGRADE, Mont., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial ...\n more…
Xtant Medical Wins Auction for Surgalign's Hardware and Biologics Business
Globe Newswire Acquisition to Enhance Xtants Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that ...\n more…
Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023
Globe Newswire BELGRADE, Mont., July 25, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June...\n more…
Xtant Medical Announces Closing of $15 Million Private Placement
Globe Newswire BELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of its previously announced $15 million private placement with ...\n more…